Infectious Disease Control News & Press Release Distribution

Infectious Disease Control

APAC
Global

Chula Medicine Reveals Detection of Latent Dementia

Thai Red Cross Emerging Infectious Diseases Health Science Center, Faculty of Medicine,Chulalongkorn University has researched a blood test for markers of Alzheimer's that can give a 10-year warning, so people can be prepared to slow down the development of dementia in old age. BANGKOK, Jan. 30,...

2023-01-30 11:01 5260

Chula Medicine Reveals Detection of Latent Dementia

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in theKingdom of Saudi Arabia(KSA) * SK bioscience also explained a new global partnership model aiming to promote public health in deve...

2023-01-27 20:00 5064

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing...

2023-01-18 21:00 4103

CGTN: China's COVID-19 vaccines proven safe, effective by trials and data

BEIJING, Jan. 17, 2023 /PRNewswire/ -- COVID-19 vaccines produced in China have been proven to be safe and effective by clinical trials and real-world data. The vaccines have helped save people inChina and around the world, which is an irreversible accomplishment and cannot be challenged by denia...

2023-01-17 23:50 3686

CGTN: China protects lives, shares experience in global COVID-19 fight

BEIJING, Jan. 16, 2023 /PRNewswire/ -- Chinese people are embracing a bustling winter after the country downgraded its COVID-19 management policies. It's a breakthrough in the country's three-year fight against the pandemic, but challenges still lie ahead. Along the journey, China went all out...

2023-01-16 07:29 3972

Looking Back on Three Years of COVID-19 in China

BEIJING, Jan. 13, 2023 /PRNewswire/ -- A news report from Beijing Review: A lantern fair in Shanghai’s Yuyuan Garden attracts crowds of visitors on January 12, 2023 (WEI YAO) Entering ...

2023-01-13 22:29 4581

Looking Back on Three Years of COVID-19 in China

CGTN: TCM continues to play significant role in treating COVID-19

BEIJING, Jan. 11, 2023 /PRNewswire/ -- Traditional Chinese Medicine (TCM) has been playing an important role inChina's fight against COVID-19. As China is shifting the focus of its COVID-19 response from preventing infections to protecting people's health and preventing severe cases, the unique...

2023-01-11 23:09 4739

Global Times: Connected in recognition: Foreign ambassadors signal a welcome for China's optimized, responsible COVID policy

BEIJING, Jan. 11, 2023 /PRNewswire/ -- As of January 8, China downgraded the management of COVID-19 from category A to the less serious category B infectious disease in light of the evolving epidemic. The Chinese government has optimized measures to combat the epidemic in accordance with the soci...

2023-01-11 18:24 2722

Global Times: 'Zhang Wenhong phenomenon' shows inclusiveness of China's public opinion sphere; policymaking based on science helps nation firmly hold strategic initiative of epidemic fight

BEIJING, Jan. 11, 2023 /PRNewswire/ -- On Friday, China released the 10th edition of the COVID-19 prevention and control protocol. Moreover, starting from Sunday, the country downgraded the management of COVID-19 from Class A to Class B and lifted quarantine requirements for inbound travelers. Th...

2023-01-11 17:49 2350

CGTN: China downgrades COVID-19 rules as nation readies for normal life

BEIJING, Jan. 9, 2023 /PRNewswire/ -- China put its downgraded COVID-19 measures into force on Sunday as the nation began to resume normal life after three years of strict pandemic management. The nation reopened its border p...

2023-01-09 10:42 4414

CGTN: China downgrades COVID-19 rules as nation readies for normal life

China welcomes first arrivals following downgraded COVID management

BEIJING, Jan. 9, 2023 /PRNewswire/ -- A report from People's Daily: The first flights underChina's new COVID-19 management for international travelers arrived at airports in southChina's Guangdong province on Jan. 8, according to the national customs authority. Over 380 passengers were aboard tw...

2023-01-09 07:40 2975

Global Times: China shifts COVID policy with necessary conditions

BEIJING, Jan. 5, 2023 /PRNewswire/ -- After three years' hard efforts to keep COVID-19 at bay,China has optimized its virus response and come up with a major shift in its epidemic policy by downgrading COVID management and announcing the reopening of international borders fromJanuary 8, 2023. Glo...

2023-01-05 23:21 2698

CGTN: China's preparedness for adjusting its COVID-19 policies

BEIJING, Jan. 5, 2023 /PRNewswire/ -- Since China prioritized its COVID-19 response from the dynamic zero-COVID policy, some Western media and intellectuals have been questioningChina's "preparedness" of making the change. Preparedness can ...

2023-01-05 04:07 3384

CGTN: China's preparedness for adjusting its COVID-19 policies

CGTN: China's dynamic zero-COVID policy sets the foundation for reopening

BEIJING, Jan. 5, 2023 /PRNewswire/ -- China has adjusted its response to COVID-19 prevention and control in recent weeks. It announced it will downgrade COVID-19 management from Class A to Class B infectious disease while resuming passport, visa issuance and easing border-entry policies starting ...

2023-01-05 04:05 3715

CGTN: China's dynamic zero-COVID policy sets the foundation for reopening

China's optimization of control measures lays solid foundation for COVID-19 response

BEIJING, Jan. 4, 2023 /PRNewswire/ -- A report from People's Daily: Local authorities and relevant departments inChina have been making unremitting efforts recently to ensure the supply of medical resources, satisfy the demand for medicines and focus on the prevention and treatment of high-risk g...

2023-01-04 15:39 3036

Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company

--Focus on renal disease and mRNA platform portfolios-- --Build out commercialization capabilities in preparation for the potential approval and launch of Nefecon and Xerava inChina in 2023-- --Leverage both in-house discovery and strategic business development to establish industry leadership ...

2023-01-03 16:00 4700

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

BEIJING, Jan. 3, 2023 /PRNewswire/ -- With China loosening its COVID-19 restrictions, some experts have expressed concern thatChina's relaxation of COVID-19 limitations will enhance the likelihood of the virus mutating. "It is a worry," said CNN, citing William Schaffner, professor at the Divisi...

2023-01-03 08:27 2924

CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address

BEIJING, Jan. 1, 2023 /PRNewswire/ -- From medical professionals to delivery men and women, from community workers to next-door neighbors, ordinary Chinese people are doing their best and lending a hand to help others cope with the latest waves of COVID-19 infections in the country. &amp...

2023-01-03 07:52 2974

CGTN：How do emergency wards in China cope with increasing COVID patients?

BEIJING, Jan. 3, 2023 /PRNewswire/ -- Ninety-year-old Qu Fucheng was waiting for his COVID-19 treatment in Wuhan Zhongnan Hospital when his son realized how crowded the emergency department was. "My father was in very critical ...

2023-01-03 06:54 3238

CGTN：How do emergency wards in China cope with increasing COVID patients?

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

GAITHERSBURG, Md., Dec. 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination (CI...

2022-12-30 21:00 4967

1 ... 8 9 101112 13 14 ... 33